Fullerly

Fullerly Board · Cash

Raise money or cut costs?

One saved meeting. The verdict and the plan come first; the full debate is underneath if you want to check the reasoning.

  • A saved meeting, unedited
  • Simulated board
  • Schools of thought from the public record
  • Not advice

The decision

We have 14 months of runway. Raise now at a lower valuation, or cut costs to reach break-even?

RESHAPE

RESHAPE: sell no equity yet; this week confirm whether SGD 95,000 is total costs or loss after revenue, then work toward break-even by offering existing clinics the March price rather than cutting staff, and take a small bridge from your existing backers if confirmed runway projects below 9 months.

How the five seats voted

  • RESHAPEThe CompounderYour March price rise held sign-ups, which is evidence of pricing power, and pricing power is the cheapest capital you will ever raise.
  • RESHAPEThe Visionary BettorYou are growing about 70% a year and sign-ups held after you raised prices.
  • RESHAPEThe Systems ScepticYou cannot price a raise or size a cut until you know your real burn, and on your own numbers that burn could be tiny or large.
  • RESHAPEThe AI-Era FounderYour growth and pricing power are working.
  • RESHAPEThe RivalA cut that slows your sales or a cheap round I can quote to your clinics both help me more than they help you.

The plan

  1. This week, through 2026-11-27 · You

    Get total monthly costs (with a breakdown), net monthly burn and today's bank balance from your finance file or accountant, confirm how and when existing clinics renew, then offer the March price to existing clinics as they come due and track renewals, revenue per renewal, monthly revenue and cash every week for 30 days.

  2. By 2026-11-04 · You

    Ask both existing backers for indicative bridge terms in writing, without sharing any valuation figure, and have a qualified finance professional review them.

  3. By 2026-12-31 · You

    Give both backers your decision based on the confirmed burn, the renewal results and monthly revenue.

Then decide this yourself

Is SGD 95,000 what leaves your bank each month in total, or what you lose after clinics pay you, and what do your 9 staff, rent and tools cost each month?

GO backs one option as it stands, KILL means do nothing or stop, RESHAPE means go ahead only with a named change.

In the app you make the final call in your own words; it goes into a decision journal with a 90-day review date.

Fullerly can do this next

Fullerly Agents Prototype

Agents that will run a firm's recurring work, with a record of every step. A prototype, looking for design partners.

A separate tool. Nothing from this meeting is sent to it.

See Fullerly Agents

Read the full meetingThe brief, five cases with their sources, the cross-examination and the Chair's reasoning

Step 1 · The decision brief

We have 14 months of runway. Raise now at a lower valuation, or cut costs to reach break-even?

The options

  • Raise now; Cut costs to break-even within 9 months; Raise a small bridge from existing backers

Constraints

cash: 14 months of runway; time: two backers want a decision this quarter; people: 9 staff

Step 2 · Opening round

Five seats vote and make their case.

Each seat argues independently: it votes GO, KILL or RESHAPE, makes its case, then puts one question to the owner and proposes a 30-day test.

The Compounder

A school of thought, drawn from the public record of Warren Buffett, Charlie Munger, Mark Leonard, John Malone

RESHAPE

The question this school always asksWhat is it worth, and what does it compound into over 20 years?

Your March price rise held sign-ups, which is evidence of pricing power, and pricing power is the cheapest capital you will ever raise.

Selling equity while you are unsure whether you even lose money means paying with your scarcest asset at an unknown price.

Count it with your own numbers. ARR of SGD 1.1m is roughly SGD 92,000 a month. Fourteen months at SGD 95,000 implies about SGD 1.33m in the bank, and that figure is an estimate. If the 95,000 is total costs, you are within a few thousand a month of break-even, and a raise at a lower valuation sells cheap ownership to solve a problem you may not have. If it is net, your costs are near SGD 187,000 and you do need money. What is the business worth? My estimate is that it cannot be valued today, because the last valuation and the true burn are both blank. What compounds over 20 years is the ownership you did not sell cheap. Run the See's Candies test before cutting people: customers who accepted a higher price without leaving should be offered it first. An accountant must confirm the financial side, and an SME Centre diagnosis costs nothing.

The question you must answer

Is SGD 95,000 what you spend each month, or what you lose after revenue comes in?

The 30-day test

On Monday, get net monthly burn confirmed in one line by whoever keeps your books. Then offer the March price to existing clinics as they renew, and track renewals, revenue and cash weekly for 30 days.

Pass if repriced clinics keep annualised revenue growth at 50% or more and your projected runway never drops below 9 months without a raise. If the projection drops below 9 months, take the small bridge from your existing backers and stop.

Simulated seat. The words above are generated and speak for no one named here.

The Visionary Bettor

A school of thought, drawn from the public record of Masayoshi Son, Peter Thiel, Sam Altman

GO

The question this school always asksWhat is the 10-year bet, and what would make it a monopoly?

You are growing about 70% a year and sign-ups held after you raised prices, so you appear to have a curve with pricing power, and cutting costs to break even would trade that curve for safety you do not yet need.

Holding prices while sign-ups hold is early evidence that you could own the clinic niche outright, and a lower valuation now matters little next to owning that corner over ten years.

Here is my estimate, with the working shown. If SGD 95,000 is your net burn, then 14 months of runway means roughly SGD 1.33m in the bank. If 95,000 is your total costs, then revenue of about SGD 92,000 a month would put you close to break-even already, and "14 months" could not be right. Either way, you need to find out which it is this week. The Thiel lens asks what secret you hold, and your March price rise is the closest thing to one: clinics pay more and stay. Option 2 cuts into the same team that produces the 70%. The price of the raise should be set against ARR of about SGD 1.1m growing 70%, and an adviser should test that price. A qualified finance professional must check the terms and the dilution before you sign anything.

The question you must answer

Is the SGD 95,000 what you spend in a month, or what you lose in a month after revenue comes in?

The 30-day test

Starting Monday, pull the last 3 months of bank statements to fix your true net burn and cash. Then open talks with your two backers and at least one new investor, using the March pricing result as the headline.

By day 30, you have confirmed net burn, revenue is still growing at least 50% a year, and you hold at least one written offer that keeps runway above 9 months through 2027. If any of these fails, switch to Option 2.

Simulated seat. The words above are generated and speak for no one named here.

The Systems Sceptic

A school of thought, drawn from the public record of Bill Gurley, Werner Vogels, Benedict Evans

RESHAPE

The question this school always asksDoes this survive scale, scrutiny and the next platform shift?

You cannot price a raise or size a cut until you know your real burn, and on your own numbers that burn could be tiny or large.

This is a decision about quality of revenue: a price rise that held while you grew 70% is pricing power, and pricing power is exactly the asset a down round sells cheaply.

Here is the working, labelled as an estimate. Fourteen months at SGD 95,000 suggests roughly SGD 1.33m in the bank. Your ARR of SGD 1.1m is about SGD 92,000 a month. If the 95,000 is total costs, your net burn is closer to SGD 3,000 a month and you are already near break-even. If it is the loss after revenue, the picture is quite different. Same company, two opposite answers. The second scenario does not survive scrutiny, because any investor's first diligence question is net burn, and "not sure" in that room sets your valuation for you. I cannot give a valuation range without a last round price or a market multiple you trust, and inventing one would be theatre. A qualified professional must check the financing terms before anything is signed.

The question you must answer

Is SGD 95,000 what you spend each month, or what you lose after customers pay?

The 30-day test

By Friday, get one line from your accountant or a free SME Centre business diagnosis: total monthly costs, monthly revenue received, and bank balance three months ago and today. Then build a 9 month plan that reaches break-even on those real figures.

The plan reaches break-even while revenue still grows at least 50% a year and cash never drops below 9 months of real net burn. If no such plan exists, go to the bridge.

Simulated seat. The words above are generated and speak for no one named here.

The AI-Era Founder

A school of thought, drawn from the public record of Sam Altman, Dario Amodei, Alex Karp, Kai-Fu Lee, Winston Weinberg

RESHAPE

The question this school always asksWhat changes when intelligence is cheap, and what is the risk?

Your growth and pricing power are working, so protect the growth engine and use cheap intelligence, not layoffs, to close the gap.

A generalist reads "cut costs" as "cut people," but the cost curve that matters to you is the price of routine work, and that cost is falling every quarter.

First, the question your numbers raise. If SGD 95,000 is net burn, then fourteen months means about SGD 1.33m in the bank. If it is total costs, then you are losing about SGD 3,000 a month against roughly SGD 92,000 of monthly revenue, and you are nearly at break-even already. Those are two different companies. Next, look at where the hours go. Onboarding, support and reporting at a clinic software firm are the jobs these tools now absorb, so you can cut costs without losing the sales capacity that carries 70% growth. My school's bias is believing clinics and teams change faster than they really do, so the bridge exists to pay for that delay. On valuation, my estimate is that I cannot price it from here. The working is SGD 1.1m ARR multiplied by a figure a qualified adviser takes from recent comparable deals. On a small bridge, the price matters less.

The question you must answer

Is SGD 95,000 what leaves the bank each month in total, or what you lose after clinics pay you?

The 30-day test

On Monday, get one line from your accountant confirming net burn from the last 3 months of bank statements. Then have each of the 9 staff log their hours for two weeks, put the three largest routine tasks onto AI tools for the next two weeks, and track hours saved and revenue each week. A qualified professional should check the bridge terms. An SME Centre consultation is free and can help here.

Net burn is confirmed, and the pilot cuts monthly costs enough to reach break-even within 9 months at your current cash, while monthly revenue grows at least 3.4% (about 50% a year when compounded). If either of these fails, raise the full round now.

Simulated seat. The words above are generated and speak for no one named here.

The Rival

Composite stakeholder

RESHAPE

A cut that slows your sales or a cheap round I can quote to your clinics both help me more than they help you.

A lower valuation is not only dilution. It is a story I can tell your clinics about whether you will still be around next year.

Here is my working, labelled as an estimate. Revenue is roughly SGD 92,000 a month. If SGD 95,000 is net burn, 14 months means about SGD 1.33m in the bank. If it is total costs, you lose about SGD 3,000 a month and hold roughly SGD 42,000. Those are two different companies. The first needs money. The second is nearly break-even with no cushion. Either way, what I want most is a cheap round I can quote to your clinics, or cuts that thin your sales team while I bundle a good-enough version into software they already open daily. Your March price rise held, which tells me clinics value you more than my bundle. A quiet bridge from people who already know you keeps that lead without the headline. A qualified accountant must confirm the financial part.

The question you must answer

Is SGD 95,000 what you spend each month, or what you lose after revenue comes in?

The 30-day test

On Monday, get one line from your accountant: net burn and cash in the bank. Then, for 30 days, track runway every week and new monthly recurring revenue. Also ask each clinic you lose or nearly lose which other tool they use every week.

Runway stays at or above 9 months on the confirmed net burn, and new revenue keeps pace with at least 50% a year. If either fails, switch to cuts that leave sales untouched.

Simulated seat. The words above are generated and speak for no one named here.

Step 3 · Cross-examination

Each seat takes on another.

Each seat cross-examines another seat's case. Then each one says whether it holds or changes its vote. In this meeting, 1 of 5 seats changed their vote.

  1. The Compounder questions The Visionary Bettor

    You vote GO, then admit you do not know whether you are near break-even or burning SGD 95,000 a month. That gap is the whole decision. Selling shares at a lower valuation when you cannot say what you are worth means paying with your most expensive currency for a number you have not checked. Your own working shows one version of this company barely needs money. Raising there gives away a slice of 20 years of compounding to solve a problem you may not have. Pricing power is the better asset. The March rise held, so test it on existing clinics before you sell equity. And "cuts hurt the 70%" assumes every cost drives growth. Nobody here has shown that. Find the real burn this week. Then decide. A qualified finance professional should check any terms.

    Holds RESHAPEbecause nothing Seat B said answers whether the burn is gross or net, and that still decides whether a raise is needed at all.

  2. The Visionary Bettor questions The Compounder

    Seat A, you call pricing power the cheapest capital, then use it as a reason to stay small. That is the strikeout looking. The March price rise proves clinics want more of you, and the real question is who owns that demand in ten years. Equity you refused to sell is worth little if a bundled rival takes the category while you guard the cap table. The ownership that compounds sits in the company that ends up No.1, not the one that kept more of a niche. My bias is survivorship: I hear about the raises that paid, and leverage has hurt this school. So I concede your arithmetic. But if the burn turns out to be net, waiting is not thrift, it is drift. Confirm the burn this week, then raise for the curve, not for survival.

    Changed vote GO to RESHAPEbecause every seat has shown the same company is either nearly break-even or clearly short of cash depending on one unknown, so the bet should be sized only after you confirm net burn, with a bridge from existing backers buying that time.

  3. The Systems Sceptic questions The Visionary Bettor

    You vote GO while admitting you do not know which company this is. You also wave away the total-costs case by saying "14 months could not be right". It can. A loss of about SGD 3,000 a month over 14 months means roughly SGD 42,000 in the bank: a thin cushion, not an error. You price the raise off ARR and 70% growth, but the Gurley test is the quality of each dollar: gross margin, how it was acquired, and what the next dollar costs. Nobody here knows any of those. Raising at a lower valuation before measuring burn sells ownership blind. "Safety you do not yet need" also quietly assumes the net case. Get one line from the accountant this week, then vote. Growth with no measured burn is a narrative without numbers.

    Holds RESHAPEbecause nothing argued here tells you whether SGD 95,000 is gross or net, and every option turns on that.

  4. The AI-Era Founder questions The Visionary Bettor

    Seat B, I share your love of the curve, but your GO rests on an arithmetic slip. If SGD 95,000 is total costs, "14 months" is not impossible. It is a floor. It would mean you divided cash by gross costs, so roughly SGD 1.33m sits in the bank against a loss of a few thousand a month, and your true runway is far longer. That figure is an estimate. In that world, raising now at a lower valuation sells cheap ownership to fix nothing. My school will happily raise to ride a curve, and I own our bias: we overrate how fast clinics change. But a raise needs a stated use, such as sales or the product that cheap intelligence now makes possible. You named none. Settle the burn question this week. Then raise from strength, or bridge if the number is ugly.

    Holds RESHAPEbecause the burn is still unknown, and a GO decided before you know it is a guess with paperwork attached.

  5. The Rival questions The Visionary Bettor

    You treat the March price rise as a secret. It is not. It shows clinics will pay more, and I can see that too. What I cannot see is your burn, and neither can you. Going to market now, at a lower price, while unsure whether the SGD 95,000 is a cost or a loss, hands me a gift. A cheaper round gets noticed, and my sales team will tell every clinic you serve that you are struggling. You say cutting costs threatens the team behind the 70% growth. A rushed raise threatens the same growth, because it is my best sales pitch against you. The cheapest answer is to learn the real burn this month, then raise from strength or not at all. Speed only helps you if you know which company you are.

    Holds RESHAPEbecause nobody has yet settled whether the burn is gross or net, and that is what decides between a cut and a raise.

Step 4 · The Chair's reasoning

Every seat found the same fault: on your own numbers this is either a company losing about SGD 3,300 a month or one losing SGD 95,000 a month, and a raise at a lower valuation is unneeded in the first case and priced blind in the second until the burn is confirmed. The case for raising now rests on growth and pricing power, but nobody showed that cutting costs would slow growth, and the March price rise points to the cheapest source of cash you have.

The vote

VoteOpeningAfter cross-examination
GO10
KILL00
RESHAPE45

Where they agree

  • Confirm net monthly burn and cash in the bank before any other move; it decides everything else.
  • The March price rise that held sign-ups is real pricing power, and a cheap round sells it short.
  • Protect the people who sell to and serve clinics; growth of at least 50% a year is the success line.

The live split

If your burn proves to be net, you must choose between using the backers' interest to raise for growth now or taking only a small bridge while repricing and growth close the gap.

Against your constraints: Cutting staff to reach break-even conflicts with your goal of 50% yearly growth, and if SGD 95,000 is net burn, growth of only 50% a year breaches your 9-month runway floor in about 11 months, so the plan relies on pricing first with a bridge as the backstop.

Bring your own decision

Fullerly Board is in private testing. Ask for early access and bring the decision on your desk.

Ask for early accessHow the Board works →

Each seat is a labelled simulation of a way of reasoning, drawn from the public record of several operators. No seat is any one person, and none of them took part. Real quotes appear only in the boxes marked "From the public record", attributed and dated, kept apart from the simulation. Fullerly Board is in private testing.

Not investment, legal, financial, tax or medical advice. No person whose public words appear is affiliated with Fullerly Board or has endorsed it. Fullerly Board is provided by Aye Bot Pte. Ltd. (UEN 202549226G), Singapore.